<DOC>
	<DOCNO>NCT00292747</DOCNO>
	<brief_summary>The aim study show combination drotaverine 80mg ibuprofen 400 mg effective well-tolerated ibuprofen 400 mg drotaverine 80 mg administer alone , treatment primary secondary dysmenorrhoea .</brief_summary>
	<brief_title>Drotaverine Dysmenorrhoea Treatment</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Drotaverin</mesh_term>
	<mesh_term>Papaverine</mesh_term>
	<criteria>History least 6 month dysmenorrhea , presence moderate severe pain last 3 cycle With regular menstrual cycle ( 2535 day ) Using adequate barrier contraception method ( except virgin ) Evidence clinically relevant gynecological , cardiovascular , hematologic , hepatic , gastrointestinal , renal , pulmonary , endocrinologic , neurologic psychiatric disease , base clinical assessment routine laboratory investigation Proven hypersensitivity drotaverine hydrochloride ibuprofen proven intolerance lactose Any describe contraindication either drotaverine hydrochloride ibuprofen ( see Summary Product Characteristics ) Oestroprogestative contraception within last 2 month Regular use sedative , hypnotic , tranquillizer addictive agent History evidence acute chronic alcohol abuse Heavy smoking ( &gt; 10 cigarettes/day ) Need permanent treatment antispasmodic and/or analgesic agent trial Lactation Pregnancy Participation another clinical trial last 3 month prior start study The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>